Abstract
Search for loss of heterozygosity on chromosomes 1p, 9p, 10q, and 19q, epidermal growth factor receptor (EGFR) gene amplification, and p53 expression was performed in a series of 131 low-grade gliomas. The profile of molecular changes, clinical findings, and histology were subsequently correlated with the course of the disease, mainly progression-free survival. When these parameters were considered as candidate variables in a multivariate analysis, only loss of heterozygosity on chromosome 1p was associated with increased progression-free survival (hazard ratio, 0.521), indicating a major favorable prognostic role of this genetic alteration in low-grade gliomas. © 2005 American Neurological Association.
Cite
CITATION STYLE
Kujas, M., Lejeune, J., Benouaich-Amiel, A., Crinière, E., Laigle-Donadey, F., Marie, Y., … Delattre, J. Y. (2005). Chromosome 1p loss: A favorable prognostic factor in low-grade gliomas. Annals of Neurology, 58(2), 322–326. https://doi.org/10.1002/ana.20543
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.